Table 4.
Test index | AUC | P value | 95% CI | Threshold | Sensitivity (%) | Specificity (%) | |
---|---|---|---|---|---|---|---|
Urosepsis | N% | 0.913 | < 0.001* | 0.871–0.956 | 80.80 | 90.10 | 81.70 |
NLR | 0.929 | < 0.001* | 0.893–0.966 | 9.23 | 86.50 | 84.50 | |
La | 0.891 | < 0.001* | 0.831–0.933 | 1.71 | 79.30 | 93.00 | |
TP | 0.767 | < 0.001* | 0.699–0.836 | 39.40 | 100.00 | 0 | |
ALB | 0.821 | < 0.001* | 0.758–0.885 | 18.65 | 100.00 | 0 | |
USG | N% | 0.773 | < 0.001* | 0.684–0.863 | 90.15 | 71.20 | 72.90 |
NLR | 0.775 | < 0.001* | 0.686–0.863 | 18.44 | 73.10 | 76.30 | |
La | 0.772 | < 0.001* | 0.687–0.858 | 2.00 | 100.00 | 49.20 | |
TP | 0.696 | < 0.001* | 0.598–0.795 | 39.40 | 100.00 | 0 | |
ALB | 0.661 | 0.002* | 0.558–0.763 | 18.20 | 100.00 | 0 | |
PRE | 0.863 | < 0.001* | 0.795–0.931 | 42.10 | 80.80 | 83.10 |
The PRE variable can be used to assess the likelihood of an individual having a certain disease
PRE predicted probability, AUC area under the receiver operating characteristic curve
P-values show the level of statistical significance (*P < 0.05). Confidence intervals (CI) are provided at the 95% level